ALEXIS IBARRA: Open Payments
NPI 1992473565 · HAYS, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$280 in 13 payments from 7 companies in 2025. Trend: 2023 $32 · 2024 $178 · 2025 $280
Food & beverage: $280
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $106 |
| Novo Nordisk Inc | 3 | $73 |
| Lilly USA, LLC | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: VRAYLAR, Ozempic, Wegovy, QULIPTA, ZEPBOUND, MOUNJARO, JARDIANCE, Kerendia.
Industry payments across KS — which companies pay providers there.
